AGF Investments Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $23.4M | Buy |
534,933
+93,744
| +21% | +$4.56M | 0.22% | 108 |
|
|
2022
Q2 | $23.1M | Buy |
441,189
+14,387
| +3% | +$733K | 0.21% | 113 |
|
|
2022
Q1 | $22.1M | Sell |
426,802
-41,200
| -9% | -$2.14M | 0.17% | 128 |
|
|
2021
Q4 | $27.6M | Buy |
468,002
+1,849
| +0.4% | +$91.6K | 0.2% | 123 |
|
|
2021
Q3 | $20M | Sell |
466,153
-69,316
| -13% | -$3.07M | 0.15% | 147 |
|
|
2021
Q2 | $21M | Buy |
535,469
+44,254
| +9% | +$1.72M | 0.16% | 149 |
|
|
2021
Q1 | $17.8M | Buy |
491,215
+5,103
| +1% | +$181K | 0.14% | 159 |
|
|
2020
Q4 | $17.9M | Sell |
486,112
-46,239
| -9% | -$1.7M | 0.15% | 151 |
|
|
2020
Q3 | $18.5M | Buy |
532,351
+10,091
| +2% | +$354K | 0.19% | 146 |
|
|
2020
Q2 | $16.2M | Sell |
522,260
-3,471
| -0.7% | -$118K | 0.17% | 151 |
|
|
2020
Q1 | $16.3M | Sell |
525,731
-15,907
| -3% | -$542K | 0.2% | 133 |
|
|
2019
Q4 | $20.1M | Sell |
541,638
-40,420
| -7% | -$1.44M | 0.24% | 118 |
|
|
2019
Q3 | $19.8M | Buy |
582,058
+10,623
| +2% | +$386K | 0.25% | 115 |
|
|
2019
Q2 | $23.5M | Sell |
571,435
-4,128
| -0.7% | -$164K | 0.28% | 111 |
|
|
2019
Q1 | $23.2M | Buy |
575,563
+51,797
| +10% | +$2.07M | 0.26% | 114 |
|
|
2018
Q4 | $21.7M | Sell |
523,766
-15,163
| -3% | -$629K | 0.26% | 118 |
|
|
2018
Q3 | $22.5M | Sell |
538,929
-139,930
| -21% | -$5.39M | 0.23% | 123 |
|
|
2018
Q2 | $23.4M | Buy |
678,859
+223,205
| +49% | +$7.63M | 0.24% | 119 |
|
|
2018
Q1 | $15.3M | Sell |
455,654
-458,547
| -50% | -$15.8M | 0.17% | 148 |
|
|
2017
Q4 | $31.4M | Buy |
914,201
+345,796
| +61% | +$11.8M | 0.31% | 105 |
|
|
2017
Q3 | $19.3M | Sell |
568,405
-198,483
| -26% | -$6.38M | 0.21% | 130 |
|
|
2017
Q2 | $24.4M | Sell |
766,888
-706,565
| -48% | -$22.3M | 0.28% | 98 |
|
|
2017
Q1 | $47.8M | Buy |
1,473,453
+208,368
| +16% | +$6.57M | 0.52% | 66 |
|
|
2016
Q4 | $38.9M | Buy |
1,265,085
+186,137
| +17% | +$5.68M | 0.45% | 74 |
|
|
2016
Q3 | $34.7M | Buy |
1,078,948
+10,824
| +1% | +$362K | 0.39% | 88 |
|
|
2016
Q2 | $35.7M | Buy |
1,068,124
+35,846
| +3% | +$1.14M | 0.4% | 84 |
|
|
2016
Q1 | $29M | Sell |
1,032,278
-59,496
| -5% | -$1.7M | 0.35% | 91 |
|
|
2015
Q4 | $33.4M | Buy |
1,091,774
+199,416
| +22% | +$6.27M | 0.41% | 81 |
|
|
2015
Q3 | $26.7M | Buy |
892,358
+607,670
| +213% | +$19.5M | 0.34% | 91 |
|
|
2015
Q2 | $9.04M | Buy |
+284,688
| New | +$9.28M | 0.1% | 184 |
|
|
2014
Q2 | – | Sell |
-99,919
| Closed | -$3.04M | – | 416 |
|
|
2014
Q1 | $3.04M | Sell |
99,919
-58,497
| -37% | -$1.74M | 0.03% | 279 |
|
|
2013
Q4 | $4.61M | Buy |
+158,416
| New | +$4.61M | 0.05% | 255 |
|
Other funds holding PFE
AGF Investments Inc's PFE Position: Q3 2022 in Review
AGF Investments Inc increased its Pfizer (PFE) stake by 21% in Q3 2022, buying an estimated $4.56M and bringing the position to 534,933 shares worth $23.4M. The position accounts for 0.22% of the portfolio, ranked #108.
AGF Investments Inc first reported a position in PFE in Q4 2013 and has held it in 32 quarters since. The position peaked at $47.8M in Q1 2017. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- AGF Investments Inc held 534,933 shares of Pfizer worth $23.4M as of Q3 2022.
- AGF Investments Inc bought 93,744 Pfizer shares in Q3 2022, an estimated $4.56M.
- Pfizer made up 0.22% of AGF Investments Inc's portfolio in Q3 2022, its #108 holding.
- AGF Investments Inc first reported a position in Pfizer in Q4 2013 and has held it in 32 quarters since.
- AGF Investments Inc's Pfizer position peaked at $47.8M in Q1 2017.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.